Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released in 2018 ...
Cryptococcal disease is an opportunistic infection that occurs primarily among people with advanced HIV disease and is an important cause of morbidity and mortality in this group. By far the most common presentation of cryptococcal disease is cryptococcal meningitis, which accounts for an estimated 15% o...
Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection...
Increasing access to antiretroviral therapy (ART) has transformed the prognosis of HIVinfected patients in resource-limited settings (RLS). However, treatment coverage remains relatively low, and HIV diagnosis occurs at a late stage. As a result, many patients continue to die of HIV-related opportunistic...
Cryptococcose/diagnostic,
Flucytosine/administration et posologie,
Antifongiques/administration et posologie,
Infections opportunistes liées au SIDA/microbiologie,
Fluconazole/administration et posologie,
Amphotéricine B/administration et posologie,
Cryptococcose,
Cryptococcose/traitement médicamenteux,
Cryptococcose/prévention et contrôle,
Méningite cryptococcique/traitement médicamenteux,
Association de médicaments
